The life expectancy of patients after stenting for acute myocardial infarction is related to the presence or absence of disease recurrence and the development of complications. In general, patients with good treatment outcomes and high adherence do not have an impact on life expectancy, while the opposite is a risk. Stenting is a treatment for acute myocardial infarction that can effectively improve myocardial infarction symptoms and increase patient survival. If stenting for acute myocardial infarction has a good therapeutic effect, there are no other related complications, and the blood supply to the heart is restored, there is no significant impact on the patient’s life expectancy. If after stenting for acute myocardial infarction, the patient has other underlying diseases or does not cooperate with the follow-up treatment, and the blood vessel is blocked again, it may lead to recurrence of myocardial infarction, which may shorten the survival period of the patient, and affect life to a certain extent. Acute myocardial tissue infarction after stenting should also be followed up regularly in the hospital to understand the development of the recovery of their own condition, and if there is any discomfort, immediately seek medical attention.